Literature DB >> 25658563

Increase in isolation of Burkholderia contaminans from Spanish patients with cystic fibrosis.

M J Medina-Pascual1, S Valdezate2, G Carrasco2, P Villalón2, N Garrido2, J A Saéz-Nieto2.   

Abstract

Species of the Burkholderia cepacia complex are associated with opportunistic infection in patients with cystic fibrosis. For years now, B. multivorans and B. cenocepacia have been the most frequently isolated species within the complex in such patients. However, between 2008 and 2012, the overall incidence of these species in Spain (17.7% and 12.5% respectively) was overtaken by that of B. contaminans (36.5%). The population structure of B. contaminans isolates from Spanish patients with cystic fibrosis was analysed using multilocus sequence typing and pulsed-field gel electrophoresis (PFGE). Three major known sequence types (ST102, ST404 and ST482) and a new one (ST771) were identified among 59 isolates. In addition, PFGE detected 17 pulsotypes. Susceptibility to antibiotics was examined using the Etest. Cotrimoxazole and ceftazidime were the most active antibiotics against B. contaminans, inhibiting growth in 88% and 86% of the isolates, respectively. In addition, this species showed less resistance to most of the antibiotics tested than did either B. multivorans or B. cenocepacia isolates recovered from similar Spanish patients.
Copyright © 2014 European Society of Clinical Microbiology and Infectious Diseases. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Antimicrobial susceptibility; Burkholderia contaminans, cystic fibrosis; genetic diversity; multilocus sequence typing; pulsed field gel electrophoresis

Mesh:

Substances:

Year:  2014        PMID: 25658563     DOI: 10.1016/j.cmi.2014.07.014

Source DB:  PubMed          Journal:  Clin Microbiol Infect        ISSN: 1198-743X            Impact factor:   8.067


  17 in total

1.  SNaPBceBcon: a Practical Tool for Identification and Genotyping of Burkholderia cepacia and Burkholderia contaminans.

Authors:  Ricardo Araujo; Rita Caramalho; Carla Coutinho; Isabel Sá-Correia
Journal:  J Clin Microbiol       Date:  2015-12-09       Impact factor: 5.948

2.  Burkholderia cepacia complex in cystic fibrosis in the post-epidemic period: multilocus sequence typing-based approach.

Authors:  Libor Fila; Pavel Dřevínek
Journal:  Folia Microbiol (Praha)       Date:  2017-03-31       Impact factor: 2.099

3.  Whole Genome Sequence Analysis of Burkholderia contaminans FFH2055 Strain Reveals the Presence of Putative β-Lactamases.

Authors:  José J Degrossi; Cindy Merino; Adela M Isasmendi; Lorena M Ibarra; Chelsea Collins; Nicolás E Bo; Mariana Papalia; Jennifer S Fernandez; Claudia M Hernandez; Krisztina M Papp-Wallace; Robert A Bonomo; Miryam S Vazquez; Pablo Power; María S Ramirez
Journal:  Curr Microbiol       Date:  2019-02-19       Impact factor: 2.188

Review 4.  The art of persistence-the secrets to Burkholderia chronic infections.

Authors:  Eric R G Lewis; Alfredo G Torres
Journal:  Pathog Dis       Date:  2016-07-19       Impact factor: 3.166

5.  The first reported case of Burkholderia contaminans in patients with cystic fibrosis in Ireland: from the Sargasso Sea to Irish Children.

Authors:  Rachel F Power; Barry Linnane; Ruth Martin; Noelle Power; Peig Harnett; Brian Casserly; Nuala H O'Connell; Colum P Dunne
Journal:  BMC Pulm Med       Date:  2016-04-22       Impact factor: 3.317

6.  Draft Genome Sequences of Burkholderia contaminans FFI-28, a Strain Isolated from a Contaminated Pharmaceutical Solution.

Authors:  Maria Sol Haim; Marta Mollerach; Gary Van Domselaar; Sergio A Teves; José Degrossi; Silvia T Cardona
Journal:  Genome Announc       Date:  2016-10-27

7.  Burkholderia contaminans Colonization from Contaminated Liquid Docusate (Colace) in a Immunocompetent Adult with Legionnaire's Disease: Infection Control Implications and the Potential Role of Candida pellucosa.

Authors:  Burke A Cunha; John Gian; Bertamaria Dieguez; Elsa Santos-Cruz; Daniela Matassa; Steve Gerson; Pat Daniels; Carlos Rosales; Rodger P Silletti
Journal:  J Clin Med       Date:  2016-11-30       Impact factor: 4.241

8.  Exploring the value of MALDI-TOF MS for the detection of clonal outbreaks of Burkholderia contaminans.

Authors:  Selali Fiamanya; Lucía Cipolla; Mónica Prieto; John Stelling
Journal:  J Microbiol Methods       Date:  2020-12-29       Impact factor: 2.363

9.  Draft Genome Sequences of Burkholderia contaminans, a Burkholderia cepacia Complex Species That Is Increasingly Recovered from Cystic Fibrosis Patients.

Authors:  Ruhi A M Bloodworth; Carrie Selin; Maria Agustina López De Volder; Pavel Drevinek; Laura Galanternik; José Degrossi; Silvia T Cardona
Journal:  Genome Announc       Date:  2015-08-06

10.  Understanding the Pathogenicity of Burkholderia contaminans, an Emerging Pathogen in Cystic Fibrosis.

Authors:  Jaroslav Nunvar; Lucie Kalferstova; Ruhi A M Bloodworth; Michal Kolar; Jose Degrossi; Silvina Lubovich; Silvia T Cardona; Pavel Drevinek
Journal:  PLoS One       Date:  2016-08-11       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.